Qvance AB is a Swedish AB based in Huddinge, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2024, the company has 3 employees and reported revenue of SEK 144.0k in its latest annual filing.
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Företaget skall utföra mikrobiologiska och immunologiska analyser och kontroller primärt på avancerade terapiläkemedel samt andra läkemedel, medicintekniska substanser och produkter samt på material från prekliniskt - kliniskt utvecklingsarbete.
In its most recent annual report (2025), Qvance AB reported revenue of SEK 144.0k. The figures on this page draw on 2 annual filings covering 2024 to 2025. The bottom line showed a net loss of SEK 6.1m, and the EBITDA margin stood at -4,192.4%.
At the end of 2025, equity financed 0.7% of the balance sheet, and current assets covered short-term debt 0.7 times.
Frequently asked questions
What is the Org number of Qvance AB?
Qvance AB is registered with Bolagsverket / SCB under Org 5594736497.
What is the revenue of Qvance AB?
Qvance AB reported revenue of SEK 144.0k in 2025.
How many employees does Qvance AB have?
Qvance AB employs 3 people as of the latest annual report.
Who is the CEO of Qvance AB?
Lindsay Catrina Davies is the CEO of Qvance AB, in role since 2025.
Who is the chairman of Qvance AB?
Mathias Gösta Svahn chairs the board of Qvance AB.
